Answers are grounded in this paper and cite their sources.
Background/Objectives: Innate immune pathways may contribute to the metabolic, renal, and cardiovascular abnormalities encompassed by cardiovascular–kidney–metabolic (CKM) syndrome. We investigated whether MBL2 rs1800450 and MIF rs755622 are associated with advanced CKM stage and related clinical characteristics. Methods: This cross-sectional study included 178 adults classified as CKM stages 0–2 (n = 104) or 3–4 (n = 74). Both variants were genotyped using polymerase chain reaction–restriction fragment length polymorphism analysis. Associations with advanced CKM stage and renal, cardiometabolic, inflammatory, and hepatic parameters were assessed using age- and sex-adjusted regression models. Results: Carriage of the MBL2 rs1800450 B allele (AB + BB versus AA) was associated with higher odds of advanced CKM stage (adjusted odds ratio = 2.77, 95% confidence interval: 1.23–6.25; p = 0.014; q = 0.029). B-allele carriers also had higher serum uric acid levels (β = 0.99 mg/dL; p = 0.003; q = 0.038) and gamma-glutamyl transferase levels (β = 0.33, natural-log scale; p = 0.002; q = 0.018). Both associations persisted in additional adjusted analyses. MIF rs755622 was not significantly associated with advanced CKM stage (p = 0.138), and its nominal clinical associations did not withstand FDR correction. Conclusions: MBL2 rs1800450 B-allele carriage was associated with advanced CKM stage and selected biochemical characteristics. Further studies are needed to confirm these findings and clarify their biological significance.
No takes yet. Share an insight, caveat, or question.
Çapar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: